Cargando…

Paxlovid-Induced Tacrolimus Toxicity in the Treatment of COVID-19: A Case Report

Paxlovid(TM) (nirmaltrelvir/ritonavir) received emergency use authorization from the Food and Drug Administration (FDA) in December 2021 to treat coronavirus disease 2019 (COVID-19). Given the actions of Paxlovid on cytochrome P450-3A4 (CYP3A4) enzymes, it is imperative to check for potential drug-d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michael, Stephanie, Heilbronner, Rachel, Lloyd, Christopher M, Levitin, Howard W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Emergency Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046481/ https://www.ncbi.nlm.nih.gov/pubmed/36999105 http://dx.doi.org/10.7759/cureus.35489

Ejemplares similares

Serotonin Syndrome Precipitated by Paxlovid Initiation
por: Nasser, Nicholas G, et al.
Publicado: (2023)

Paxlovid with Caution: Novel Case of Paxlovid-Induced Tacrolimus Toxicity in a Cardiac Transplant Patient
por: Shah, Aaisha, et al.
Publicado: (2022)

Monitoring tacrolimus toxicity following Paxlovid administration in a liver transplant patient
por: Maynard, Robert D., et al.
Publicado: (2023)

Case Report: tacrolimus toxicity in the setting of concurrent Paxlovid use in a heart-transplant recipient
por: Modi, Sujal, et al.
Publicado: (2023)

Heterotopic Pregnancy: A Difficult and Rarely Considered Diagnosis
por: Crum, Joseph M, et al.
Publicado: (2023)

Treatment of acute tacrolimus toxicity with phenytoin after Paxlovid (nirmatrelvir/ritonavir) administration in a kidney transplant recipient
por: Kwon, Eun-Jeong, et al.
Publicado: (2022)

Digoxin Toxicity in a Patient with Pacemaker: A Case Report
por: Bridwell, Rachel E, et al.
Publicado: (2019)

Ranolazine Toxicity Secondary to Paxlovid
por: Casey, Bradley, et al.
Publicado: (2023)

Tacrolimus Drug–Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin
por: Sindelar, Morganne, et al.
Publicado: (2022)

DRUG INTERACTION BETWEEN PAXLOVID AND TACROLIMUS IN AN ADOLESCENT WITH INFLAMMATORY BOWEL DISEASE
por: Zaarur, Leenoy, et al.
Publicado: (2023)

Intentional Toxic Ingestion of Sodium Fluoride: A Case Report
por: Bridwell, Rachel E, et al.
Publicado: (2019)

COVID-19-Induced Phlegmasia Cerulea Dolens
por: Cohen, Stephanie, et al.
Publicado: (2023)

Comment on “Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin”
por: de Oliveira, Luciana Mello, et al.
Publicado: (2023)

Elevated tacrolimus levels after treatment with nirmatrelvir/ritonavir (Paxlovid) for COVID-19 infection in a child with a kidney transplant
por: Young, Chelsea, et al.
Publicado: (2022)

The future of Paxlovid for COVID-19
por: Burki, Talha
Publicado: (2022)

Tacrolimus: COVID-19 and toxic levels of tacrolimus: case report
Publicado: (2021)

Response to Comment on “Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin”
por: Sindelar, Morganne, et al.
Publicado: (2023)

Drug Interaction Between Tacrolimus and Paxlovid (Nirmatrelvir/Ritonavir) in an Adolescent with Inflammatory Bowel Disease
por: Zaarur, Leenoy, et al.
Publicado: (2023)

The Treatment of COVID-19 With Monoclonal Antibody Therapy: Patient-Reported Outcomes
por: Lamour, Daniella, et al.
Publicado: (2022)

Paxlovid-Tacrolimus Drug–Drug Interaction in a 23-Year-Old Female Kidney Transplant Patient with COVID-19
por: Berar Yanay, Noa, et al.
Publicado: (2022)

Streptococcal Toxic Shock Syndrome: A Case Report
por: Silva, José Miguel, et al.
Publicado: (2022)

Methadone Toxicity in a Pediatric Patient: A Case Report
por: Lumba, Palveen, et al.
Publicado: (2021)

Toxic Alcohol Ingestion: A Case Report and Review of Management Pathways
por: Atluri, Paavani, et al.
Publicado: (2021)

COVID-19-Induced Mesenteric Thrombosis
por: Hanif, Muhammad, et al.
Publicado: (2021)

Where Have All the FLOWERS Gone? A Multicenter Investigation of Frequent Users of Midwest Emergency Department Services During the COVID-19 Stay-at-home Orders
por: Levitin, Howard W., et al.
Publicado: (2022)

Use of Casirivimab and Imdevimab for the Treatment of COVID-19
por: Liu, Ryan, et al.
Publicado: (2022)

COVID-19-Induced Eosinophilic Lower Airway Inflammation in Those With Multiple COVID-19 Vaccinations
por: Fukuda, Yosuke, et al.
Publicado: (2023)

Ethylene Glycol Toxicity in the Setting of Recurrent Ingestion: A Case Report and Literature Review
por: Loriaux, Daniel, et al.
Publicado: (2019)

Warfarin-Induced Calciphylaxis in a COVID-19 Patient
por: Abutaki, Fatima H, et al.
Publicado: (2020)

Making Data Reports Useful During the COVID-19 Pandemic
por: Ma, Alfred C, et al.
Publicado: (2020)

The Path to Paxlovid
por: Halford, Bethany
Publicado: (2022)

Emerging Pharmaceutical Treatments of Novel COVID-19: A Review
por: Hussain, Azhar, et al.
Publicado: (2020)

COVID-19 Presenting as Acute Abdominal Pain: A Case Report
por: Purayil, Nishan, et al.
Publicado: (2020)

Esophageal Rupture Associated With COVID-19: A Novel Case Report
por: Meloy, Patrick, et al.
Publicado: (2020)

COVID-19-Induced Hypoxia With Accompanying Syncope Event and Traumatic Injury
por: Ordookhanian, Christ, et al.
Publicado: (2021)

Sinus Arrest in Asymptomatic COVID-19 Infection
por: Nguyen, Alexander, et al.
Publicado: (2022)

New Zealand Emergency Department COVID-19 Preparedness: a cross-sectional survey and narrative view
por: Howard, Michael James, et al.
Publicado: (2022)

Complicated Appendicitis in a Pediatric Patient With COVID-19: A Case Report
por: Alsuwailem, Abdulaziz B, et al.
Publicado: (2020)

Hypertensive Anaphylaxis After Moderna COVID-19 Vaccination: A Case Report
por: Furuto, Yoshitaka, et al.
Publicado: (2022)

COVID-19 Encephalopathy Presenting As New-Onset Seizure: A Case Report
por: Baksh, Abdullah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e33mrb628qlv42tbe5numovfp5